Hinge Health (NYSE:HNGE) Major Shareholder Insight Holdings Group, Llc Sells 181,499 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 181,499 shares of the stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $90.20, for a total value of $16,371,209.80. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Tuesday, July 7th, Insight Holdings Group, Llc sold 244,672 shares of Hinge Health stock. The stock was sold at an average price of $90.23, for a total value of $22,076,754.56.
• On Thursday, June 25th, Insight Holdings Group, Llc sold 530,982 shares of Hinge Health stock. The shares were sold at an average price of $71.82, for a total value of $38,135,127.24.
• On Monday, June 29th, Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock. The stock was sold at an average price of $82.83, for a total transaction of $121,484,027.61.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The stock was sold at an average price of $71.67, for a total transaction of $10,199,429.37.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total transaction of $27,813,744.55.
• On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total transaction of $7,897,010.17.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The shares were sold at an average price of $70.95, for a total value of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total value of $4,614,279.16.

Hinge Health Trading Up 1.6%

HNGE stock traded up $1.45 during midday trading on Thursday, hitting $89.95. The stock had a trading volume of 1,278,767 shares, compared to its average volume of 2,213,831. The firm has a market capitalization of $6.96 billion, a price-to-earnings ratio of -7.29 and a beta of 1.13. Hinge Health Inc. has a 52 week low of $30.08 and a 52 week high of $91.07. The stock has a 50-day simple moving average of $64.48 and a 200 day simple moving average of $49.91.

Hinge Health (NYSE:HNGE) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The firm had revenue of $182.31 million for the quarter. During the same period last year, the firm earned $1.30 EPS. The company’s quarterly revenue was up 47.2% compared to the same quarter last year. On average, equities analysts forecast that Hinge Health Inc. will post 1.33 EPS for the current year.

Institutional Trading of Hinge Health

Several hedge funds have recently modified their holdings of HNGE. Wells Fargo & Company MN raised its stake in shares of Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after acquiring an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Hinge Health in the 4th quarter valued at $26,000. CENTRAL TRUST Co acquired a new position in Hinge Health in the first quarter worth $37,000. First Horizon Corp boosted its stake in Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares in the last quarter. Finally, High Point Wealth Management LLC bought a new stake in shares of Hinge Health during the fourth quarter worth $46,000.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Zacks Research raised shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Wall Street Zen lowered Hinge Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 6th. Citizens Jmp increased their target price on Hinge Health from $65.00 to $80.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 6th. Barclays boosted their price target on Hinge Health from $62.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Finally, Citigroup reiterated an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $75.80.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.